Karen Israel

1.9k total citations · 1 hit paper
18 papers, 1.4k citations indexed

About

Karen Israel is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Karen Israel has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Infectious Diseases and 4 papers in Pharmacology. Recurrent topics in Karen Israel's work include Fungal Infections and Studies (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Antifungal resistance and susceptibility (3 papers). Karen Israel is often cited by papers focused on Fungal Infections and Studies (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Antifungal resistance and susceptibility (3 papers). Karen Israel collaborates with scholars based in United States. Karen Israel's co-authors include Kimberly A. Kline, Bob G. Sanders, Douglas Webb, Patricia Connolly‐Stringfield, Shane A. Norris, Michael L. Zeckel, L. Joseph Wheat, Weiping Yu, George F. Brooks and Carol A. Kauffman and has published in prestigious journals such as JAMA, The American Journal of Medicine and The Journal of Infectious Diseases.

In The Last Decade

Karen Israel

18 papers receiving 1.3k citations

Hit Papers

Disseminated Histoplasmosis in the Acquired Immune Defici... 1990 2026 2002 2014 1990 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Israel United States 14 835 627 242 172 112 18 1.4k
Kunihiko Fukuchi Japan 21 362 0.4× 183 0.3× 567 2.3× 94 0.5× 280 2.5× 88 1.4k
Robert W. Novak United States 21 404 0.5× 217 0.3× 341 1.4× 26 0.2× 83 0.7× 58 1.5k
Eugene E. Emeson United States 20 401 0.5× 168 0.3× 416 1.7× 83 0.5× 177 1.6× 46 1.8k
Ling Wang China 25 328 0.4× 575 0.9× 432 1.8× 29 0.2× 101 0.9× 96 1.8k
Mridula Bose India 20 780 0.9× 936 1.5× 419 1.7× 14 0.1× 101 0.9× 59 1.4k
Mahboob Qureshi Japan 23 925 1.1× 483 0.8× 367 1.5× 19 0.1× 79 0.7× 38 1.6k
Sita Naik India 28 574 0.7× 393 0.6× 209 0.9× 12 0.1× 55 0.5× 58 2.0k
Rajaa Al‐Attiyah Kuwait 24 561 0.7× 726 1.2× 535 2.2× 45 0.3× 89 0.8× 59 1.4k
Baibaswata Nayak India 25 912 1.1× 414 0.7× 431 1.8× 10 0.1× 81 0.7× 91 2.0k
Evan O. Gregg United Kingdom 16 183 0.2× 129 0.2× 133 0.5× 33 0.2× 44 0.4× 28 666

Countries citing papers authored by Karen Israel

Since Specialization
Citations

This map shows the geographic impact of Karen Israel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Israel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Israel more than expected).

Fields of papers citing papers by Karen Israel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Israel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Israel. The network helps show where Karen Israel may publish in the future.

Co-authorship network of co-authors of Karen Israel

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Israel. A scholar is included among the top collaborators of Karen Israel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Israel. Karen Israel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Israel, Karen, et al.. (2017). Prevalence of Extra Pulmonary Tuberculosis in Patients with Tuberculosis Attending Institutions Managed by Zanmi Lasante in Saint-Marc, Haiti. Annals of Global Health. 83(1). 162–162. 1 indexed citations
2.
Israel, Karen, Weiping Yu, Bob G. Sanders, & Kimberly A. Kline. (2000). Vitamin E Succinate Induces Apoptosis in Human Prostate Cancer Cells: Role for Fas in Vitamin E Succinate-Triggered Apoptosis. Nutrition and Cancer. 36(1). 90–100. 116 indexed citations
3.
Yu, Weiping, Karen Israel, Qiao Liao, et al.. (1999). Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis.. PubMed. 59(4). 953–61. 129 indexed citations
4.
Israel, Karen, Bob G. Sanders, & Kimberly A. Kline. (1995). RRR‐α‐tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways. Nutrition and Cancer. 24(2). 161–169. 76 indexed citations
5.
McKinsey, D. S., Barry P. Katz, John R. Black, et al.. (1994). Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome. The American Journal of Medicine. 96(6). 504–508. 38 indexed citations
6.
Wheat, L. Joseph, Patricia Connolly‐Stringfield, Karen Israel, et al.. (1990). Disseminated Histoplasmosis in the Acquired Immune Deficiency Syndrome. Medicine. 69(6). 361–374. 469 indexed citations breakdown →
7.
Sharkey, P. K., John R. Graybill, Michael G. Rinaldi, et al.. (1990). Itraconazole treatment of phaeohyphomycosis. Journal of the American Academy of Dermatology. 23(3). 577–586. 166 indexed citations
8.
Kotylo, Patricia K., et al.. (1989). Subcutaneous Phaeohyphomycosis of the Finger Caused byExophiala spinifera. American Journal of Clinical Pathology. 91(5). 624–627. 37 indexed citations
9.
Israel, Karen, Henry R. Black, Gordon Brier, J. D. Wolny, & K A DeSante. (1982). Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects. Antimicrobial Agents and Chemotherapy. 22(1). 94–102. 6 indexed citations
10.
DeSante, K A, et al.. (1982). Effect of probenecid on the pharmacokinetics of moxalactam. Antimicrobial Agents and Chemotherapy. 21(1). 58–61. 17 indexed citations
11.
Israel, Karen, et al.. (1981). Disulfiram-like Reaction to  -Lactams. JAMA. 245(20). 2027–2028. 19 indexed citations
12.
Black, Henry R., Karen Israel, Robert L. Wolen, et al.. (1979). Pharmacology of Cinoxacin in Humans. Antimicrobial Agents and Chemotherapy. 15(2). 165–170. 23 indexed citations
13.
Kauffman, Carol A., Karen Israel, James W. Smith, et al.. (1978). Histoplasmosis in immunosuppressed patients. The American Journal of Medicine. 64(6). 923–932. 178 indexed citations
14.
Israel, Karen, et al.. (1978). Cinoxacin: Pharmacokinetics and the Effect of Probenecid. The Journal of Clinical Pharmacology. 18(10). 491–499. 15 indexed citations
15.
Israel, Karen, et al.. (1976). Aspects of the Pharmacology and Toxicology of Tobramycin in Animals and Humans. The Journal of Infectious Diseases. 134(Supplement 1). S97–S103. 19 indexed citations
16.
Brooks, George F., Karen Israel, & B H Petersen. (1976). Bactericidal and Opsonic Activity against Neisseria gonorrhoeae in Sera from Patients with Disseminated Gonococcal Infection. The Journal of Infectious Diseases. 134(5). 450–462. 56 indexed citations
17.
Israel, Karen, et al.. (1975). NEONATAL AND CHILDHOOD GONOCOCCAL INFECTIONS. Clinical Obstetrics & Gynecology. 18(1). 143–151. 11 indexed citations
18.
Murad, Tariq M., Karen Israel, & Jack C. Geer. (1969). Ultrastructural Cytopiasmic Changes of Adrenal Cortex During Pregnancy. Proceedings annual meeting Electron Microscopy Society of America. 27. 298–299. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026